Platinum Equity to acquire Energy Distribution Partners after 45 acquisitions and threefold EBITDA growth
Senores Pharmaceuticals (SENORES) targets 3.2bn annual manufacturing units, yet 50% to 70% utilisation raises a bigger question
Aspen Neuroscience (ASPE) prices $140.6m IPO at $15 as Parkinson’s therapy enters pivotal development phase
Read More Pharma Industry News Why Celcuity’s FDA priority review for gedatolisib could reset the breast cancer playbook Celcuity earns FDA priority review for gedatolisib in advanced breast cancer. Find out what the July 2026 PDUFA date means for its market trajectory. byPallavi MadhirajuJanuary 21, 2026